Manuel, Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry, International Journal of Cardiology (2016Cardiology ( ), doi: 10.1016Cardiology ( /j.ijcard.2016 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Introduction
Heart failure (HF) is a growing public health problem with high prevalence, morbidity and mortality especially in older patients 1 . A major challenge in the management of HF is the availability of reliable and simple tools that enable patients and physicians to have a realistic expectation of prognosis, and to guide treatment options. A number of risk models have been proposed obtained mostly through observational studies or clinical trials in patients with systolic HF less than 70 years [2] [3] [4] [5] [6] [7] [8] . We previously developed a risk model from the SENIORS dataset, based on widely available clinical and laboratory variables to predict prognosis in ambulant HF more than 70 years 9 , and have recently validated its usefulness in the RICA register of elderly patients with acute HF and mostly preserved ejection fraction 10 .
Heart rate (HR) and systolic blood pressure (SBP) are powerful prognostic factors.
Increased HR or lower SBP are independently associated with higher risk of morbidity and mortality 11, 12 . As HR and SBP are established as important prognostic variables, combining these factors could improve risk assessment compared to using them individually. We assessed the value of the combination of SBP and HR in the prognostic stratification of elderly patients with heart failure in a "real world|" clinical setting. In this analysis we collected baseline information 3 months after discharge for acute HF to avoid clinical instability, and outcomes were evaluated in those patients  70 years old with at least a follow-up of 12 months from discharge (average of 9 months follow up). Main outcome was all-cause (AC) mortality. Secondary end-points were HF readmission or the composite of AC mortality or HF readmission.
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Statistical analysis.
For SBP the cutoffs point were based on the tertiles of the sample (120 and 140 bpm) and in the case of HR the cutoff point resulted to be the same that in the BEAUTIFUL study (70 bpm) 15 to analyse the risk pattern using hazard ratios and 95% confidence M A N U S C R I P T The multivariate analysis was performed using the stepwise model, selecting those variables with a statistical p significance < 0.10 in the univariate analysis Statistical analysis was performed using SPSS Statistics 21.0 (SPSS Inc, Chicago, IL, USA). Statistical significance was defined P-value less than 0.05.
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Results
Patients
A total of 1551 patients were included with mean age was 82 years and 56 % were women. Patients were divided into three groups according to their risk based on the combined HR and SBP groups; low-risk (n: 176) moderate risk (n: 1089) and high-risk (n:286). At final follow-up 191 patients had died (12.3%), 191 were readmitted (12.0%), and 360 (23%) were readmitted or dead.
Baseline clinical characteristics 3 months after discharge, overall and in the combined HR & SBP strata risk subgroups are shown in Table 1 . NYHA III class, AF, NTproBNP and use of spironolactone were associated with high-risk group, while diabetes, BMI and serum sodium with low-risk group. There were no apparent differences in comorbidities, LVEF and other clinical and biological data.
Mortality using HR and SBP alone.
Using HR strata of <70 and >= 70 bpm we found mortality rates of 9.8 and 13.6%, respectively (hazard ratio 1.0 and 1.35). For SBP >=140, 120-140 and <120 mmHg, mortality rates were 8.2, 10.4 and 20.3%. respectively (hazard ratio 1.0, 1.34 and 2.76).
Mortality in the three risk groups combining HR and SBP
Using combined strata of HR < 70 bpm and SBP >= 140 mmHg (n=176; low risk), HR <70 and SBP <140 + HR >= 70 and SBP < 120 (n=1089; moderate risk) and HR >= 70
and SBP < 120 (n=286; high risk) we found mortality rates of 4.5%, 11.0% and 24.0%, respectively from 3 months to 12 months after discharge (P<0.001) ( Figure 1 , Table 2 ).
Multivariate Cox regression for all-cause mortality shows for low-, middle-and highrisk groups was 1 (reference), 1.93 (95% CI: 0.93 -3.99, p = 0.077) and 4.32 (95% CI:
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2.04 -9.14, p < 0.001). BMI, NYHA, MDRD, hypertension and sodium were also independent prognostic factors.
There were no significant differences in readmission rates in the three groups. For the composite outcome of HF readmission or AC mortality, rates were 16%, 22% and 34%
in the low-, moderate-and high-risk groups, respectively (p < 0.001), driven by differences in AC mortality (data not shown).
Mortality in the risk groups combining HR and SBP in patients with sinus rhythm.
Sinus rhythm was observed in 540 patients (35 % of total) with an overall mortality of 12%. In the low-, moderate-and high-risk groups mortality rates were 2.6%, 10% and 29% (hazard ratio 1.0, 4.0 and 15.9, respectively (p <0.001; Figure 2 ). The sinus rhythm group had similar results to the overall group for readmission and composite of readmission or AC mortality (data not shown).
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Discussion
This is the first analysis combining information about HR and SBP in elderly patients with HF and a great percentage with preserved systolic function and atrial fibrillation,
showing an improved ability to distinguish low-, moderate-and high-risk groups for allcause mortality, compared to each one alone. Our cohort included elderly HF patients with high rates of AF and preserved ejection fraction, receiving treatments similar to other "real world" registries 16, 17 . The simplicity of this risk model could make it easier to translate into clinical practice than more complex models.
Our findings are consistent with another publication combining HR and SBP to predict mortality in HF but this was in a younger cohort (mean age 68) and sinus rhythm 17 . We provide further evidence showing that the prognostic value of combining HR and SBP is also applicable to older patients with mixed sinus rhythm and AF.
Previous studies have demonstrated the relationship of increased HR with adverse outcomes in HF 11 . The mechanisms are not entirely clear but it is possible that tachycardia with reduced myocardial contractility leads to deteriorating cardiac output.
It is possible that the adverse effects of faster HR is different in sinus rhythm vs AF. In line with this, a meta-analysis of individual patients data of beta-blockers in HF has
shown a lack of benefit of beta blockers in patients with AF 18 . Our study supports this finding, since the gradation of mortality risk was higher in patients with sinus rhythm.
Lower blood pressure has been also established as an adverse prognostic factor in HF 12 , 19 . A plausible explanation could be poor tissue perfusion associated with impaired heart function and a worse prognosis.
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In general established risk factors tracked the risk stratification gradient for HR and SBP except for diabetes and high BMI which were more frequent in the lower risk group which is different to previous observations [20] [21] [22] . High BMI is associated with a better prognosis in HF, and is also associated with diabetes and this may partially explain this observation 23 .
Several risk models in HF have been developed and validated, using data from observational studies and clinical trials, but these have mostly included patients younger than 70 years with systolic dysfunction 24 -27 . Since HF is a disease predominantly affecting the elderly, it would be of importance to have a risk stratification tool specific for this patient population. Using the SENIORS cohort, we generate a risk model with a number of clinical and laboratory variables in stable HF patients older than 70 years, that was validate in another RICA registry study 9, 10, 29 . Our study using combining only two variables, HR and SBP, might add value because it is simpler to use in clinical practice.
Limitations
The aim was to include HF patients admitted to general internal medicine wards but some of the sicker patients were unable to give consent which could have introduced a selection bias. The moderate-risk group is much larger than the lower and high risk groups, but we did not think that it could have significantly influence the results. The HR and SBP thresholds for each group were selected, arbitrarily, based on previous studies, however they work well in our analysis. Finally we have not performed an internal validation exercise e.g. partitioning the cohort into derivation and validation sample. Previous experience shows that this approach overestimates the validity of a
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risk prediction model and the only reliable way to test the usefulness of the model is to apply it to a separate cohort ideally prospectively 9 .
Conclusions:
These results suggest that an approach of combining HR and SBP may provide a simple and reliable clinical tool for mortality risk assessment in HF that could be used in clinical practice in elderly patients. This approach could also be tested in other cohorts and against existing risk models.
Appendix:
RICA Registry members: HR: hazard ratio; CI: confidence interval; * heart rate < 70 bpm and systolic blood pressure >= 140 mmHg; **heart rate < 70 bpm & systolic blood pressure < 140 mmHg and heart rate >=70 bpm & systolic blood pressure >=120 mmHg; ***heart rate >=70 bpm and systolic blood pressure < 120 mmHg; BMI: Body mass index; DBP: diastolic blood pressure; NYHA: New York
